Found: 30
Select item for more details and to access through your institution.
Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5617, doi. 10.1002/alz.14073
- By:
- Publication type:
- Article
Prognostic prediction of the longitudinal cognitive trajectory of amyloid‐positive patients with mild dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.080613
- By:
- Publication type:
- Article
Detection of brain Tau deposition across Braak stages using plasma pTau181, MRI, and cognitive function assessments.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080575
- By:
- Publication type:
- Article
The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 4, p. 1227, doi. 10.1002/alz.12748
- By:
- Publication type:
- Article
Strategies for diverse participant recruitment to a preclinical Alzheimer's Disease prevention trial: The AHEAD study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 1, doi. 10.1002/alz.068222
- By:
- Publication type:
- Article
Diversity in Phase 2 and Phase 3 Placebo‐Controlled, Double‐Blind, Lecanemab and Elenbecestat Early Alzheimer's Disease Studies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.069198
- By:
- Publication type:
- Article
Lecanemab (BAN2401) Infusion Reactions and Immunogenicity: Results from Randomized Phase 2 Study and an Open‐Label Extension (OLE).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.066289
- By:
- Publication type:
- Article
Derivation and evaluation of signatures using plasma β‐amyloid and pTau‐181 for brain amyloid‐β detection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.067811
- By:
- Publication type:
- Article
Preliminary assessment of the clinical effects of lecanemab following 18 months of treatment in the open label extension of the phase 2 proof of concept study, BAN2401‐G000‐201, in subjects with early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057780
- By:
- Publication type:
- Article
Plasma Aβ 42:40 ratio tracks with changes in brain amyloid PET SUVr in the core and open label extension of the phase 2 proof of concept study ban2401‐g000‐201 following treatment with lecanemab in subjects with early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057760
- By:
- Publication type:
- Article
Baseline characteristics for CLARITY AD: A phase 3 placebo‐controlled, double‐blind, parallel‐group, 18‐month study evaluating lecanemab (ban2401) in early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054331
- By:
- Publication type:
- Article
AHEAD 3‐45 study: Preliminary screening and baseline characteristics from a placebo‐controlled, double‐blind study evaluating lecanemab in participants with preclinical Alzheimer's disease and elevated (A45 trial) and intermediate (A3 trial) amyloid
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.053143
- By:
- Publication type:
- Article
A preliminary assessment of longitudinal amyloid status in the ongoing open‐label extension phase in subjects with early Alzheimer's disease: Human/Human trials: Anti‐amyloid.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046209
- By:
- Publication type:
- Article
A preliminary account of ARIA‐E in the ongoing open‐label extension phase of BAN2401‐G000‐201 in subjects with early Alzheimer's disease: Human/Human trials: Anti‐amyloid.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046059
- By:
- Publication type:
- Article
AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer's disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial): Clinical trial design and implementation
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044511
- By:
- Publication type:
- Article
DT‐01‐01: BAN2401 IN EARLY ALZHEIMER'S DISEASE: NEURODEGENERATION BIOMARKER ANALYSIS FROM A RANDOMIZED PHASE 2 STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1484, doi. 10.1016/j.jalz.2019.08.004
- By:
- Publication type:
- Article
Perampanel for adjunctive treatment of partial-onset seizures: A pooled dose-response analysis of phase III studies.
- Published in:
- Epilepsia (Series 4), 2014, v. 55, n. 3, p. 423, doi. 10.1111/epi.12527
- By:
- Publication type:
- Article
Lecanemab for Patients With Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 4, p. e237230, doi. 10.1001/jamanetworkopen.2023.7230
- By:
- Publication type:
- Article
ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2023, v. 9, n. 1, p. 1, doi. 10.1002/trc2.12377
- By:
- Publication type:
- Article
Neonatal Cocaine-Related Seizures.
- Published in:
- Journal of Child Neurology, 1990, v. 5, n. 1, p. 60, doi. 10.1177/088307389000500115
- By:
- Publication type:
- Article
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study.
- Published in:
- Alzheimer's Research & Therapy, 2022, p. 1, doi. 10.1186/s13195-022-01124-2
- By:
- Publication type:
- Article
Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01129-x
- By:
- Publication type:
- Article
Correction: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correction: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00813-8
- By:
- Publication type:
- Article
Felbamate monotherapy: controlled trial in patients with partial onset seizures.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Status epilepticus following withdrawal of allopurinol.
- Published in:
- Annals of Neurology, 1990, v. 27, n. 6, p. 691, doi. 10.1002/ana.410270620
- By:
- Publication type:
- Article
Complex partial status epilepticus provoked by 'crack' cocaine.
- Published in:
- Annals of Neurology, 1989, v. 26, n. 6, p. 785, doi. 10.1002/ana.410260617
- By:
- Publication type:
- Article
A comparison of stapedial reflex fatigue with repetitive stimulation and single-fiber emg in myasthenia gravis.
- Published in:
- Annals of Neurology, 1981, v. 9, n. 6, p. 531, doi. 10.1002/ana.410090604
- By:
- Publication type:
- Article